Teva Says U.S. FDA Approves Aerosol Treatment of Nasal Allergies
Teva Pharmaceutical Industries Ltd. (TEVA) said the U.S. Food and Drug Administration has approved its QNASL nasal aerosol for the treatment of nasal allergies. The product will be available by prescription in April 2012, Teva said in a Business Wire statement today.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at firstname.lastname@example.org
To contact the editor responsible for this story: Gwen Ackerman at email@example.com